edf40wrjww2CF_PaperMaster:Desc
1 ONCOLOGY INDUSTRY ANALYSIS
1.1 Key trends and characteristics of Cytostatic industry
• high growth rate – higher propotion of the global pharma market in the years to come
• one of the fastest growing and most profitable therapeutic areas of the next few decades
• shift from accute cancer treatment to chronic disease management and prevention
• more and more biotech companies enter the market – connections with pharma to help through the maze of regulatory processes and clinical development
• patient advocacy programs
1.2 Opportunities of L therapeutic class to pharma companies
• large unmet medical needs -
o 5 mil new cases every year, second leading causes of dead
o according to WHO 10 mil cases in 2000 and expected to grow to 14,7 mil within next 20 years
• low volume, high price
• small marketing resources (hospitals, tenders)
• significant off-label usage
• favoruable reimbursment environment – global healthcare expenditure for cancer exceed $110 bn
1.3 Oncology industry
The attraction of the cancer market to the pharmaceutical and biotechnology industry is as follows by Global Equity Research (Cancer, New Frontiers, UBS Warburg, October 2001):
? large unmet medical need
? low volume, high price
? small marketing resource
? sma ...